US$ 21.32
glp-1 agonist cardiovascular outcomes Summary of outcome trials with SGLT-2 inhibitors and GLP-1 receptor agonists and cardiovascular
Description
Oral semaglutide for type 2 diabetes: a systematic review and meta-analysis

While Ozempic itself only comes as an injectable, a pill version of semaglutide called Rybelsus is available

Sthle M, Hellberg S, Virta J, Liljenbck H, Metsl O, Li XG, Jauhiainen M, Saukko P, Yl-Herttuala S, Nuutila P

Ishy PL, Fagerlund B, Broberg BV, Bak N, Knop FK, Glenthj BY, et al

Circulation 142(17):e265e286 American Diabetes Association Professional Practice Committee (2024) 10

A., Badr, O